Buchheit Kathleen M, Bernstein Jonathan A
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass.
Department of Internal Medicine, Division of Immunology/Allergy Section, University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):566-574. doi: 10.1016/j.jaip.2017.01.019.
Hypersensitivity to progestogen, previously known as autoimmune progesterone dermatitis, is an increasingly recognized clinical entity that presents specific diagnostic and treatment challenges. Clinical presentations are heterogeneous, but can consist of hypersensitivity symptoms associated with the progesterone surge during the luteal phase of the menstrual cycle or after exposure to exogenous progestins. With the increasing use of exogenous progesterone for contraception and fertility, more cases of hypersensitivity to exogenous progestins have been described. Here we will review proposed pathomechanisms for progestogen hypersensitivity (PH) as well as the clinical presentation of PH, testing strategies to aid in diagnosis, and treatment options for patients with hypersensitivity to progestogens.
对孕激素过敏,以前称为自身免疫性孕酮性皮炎,是一种日益被认识到的临床病症,它带来了特定的诊断和治疗挑战。临床表现具有异质性,但可能包括与月经周期黄体期孕激素激增或接触外源性孕激素后相关的过敏症状。随着外源性孕酮在避孕和生育方面的使用增加,更多外源性孕激素过敏的病例被描述。在此,我们将综述关于孕激素过敏(PH)的推测发病机制、PH的临床表现、有助于诊断的检测策略以及孕激素过敏患者的治疗选择。